Key result
Admission to revascularization-capable hospitals was associated with higher conformity to 8 of 19 care quality measures for ACS patients, including clopidogrel use.
Why the study?
Does admission to revascularization-capable hospitals improve conformity with performance and quality measures in acute coronary syndrome patients?
Cohort (n=95,999)
Yes
Does admission to revascularization-capable hospitals improve conformity with performance and quality measures in acute coronary syndrome patients?
Admission to revascularization-capable hospitals is associated with modestly better adherence to several guideline-directed performance and quality measures for acute coronary syndrome patients.
Answers are grounded in this paper and cite their sources.
Should not yet alter ACS triage decisions; leaves open whether capability causally improves outcomes.
BACKGROUND: Revascularization availability at US hospitals varies and may impact care quality for acute coronary syndrome patients. HYPOTHESIS: The hypothesis of this study was that there would be differences in care quality at Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) hospitals based on revascularization capability. METHODS: For acute coronary syndrome patients admitted to GWTG-CAD hospitals between 2000 and 2010, care quality at hospitals with or without revascularization capability was examined by assessing conformity with performance and quality measures. RESULTS: This study included 95 999 acute coronary syndrome patients admitted to 310 GWTG-CAD hospitals. There were 89 000 patients admitted to 226 revascularization-capable hospitals and 6999 patients admitted to 84 hospitals without revascularization capability included. Adjusted multivariate analysis demonstrated that 8 of the 19 measures were more frequently performed in the revascularization cohort: aspirin (odds ratio [OR]: 1.41, 95% confidence interval [CI]: 1.04-1.92), clopidogrel (OR: 2.31, 95% CI: 1.78-3.00), lipid-lowering therapies at discharge (OR: 1.39, 95% CI: 1.04-1.87), lipid-lowering therapies for low-density lipoprotein >100 mg/dL (OR: 1.85, 95% CI: 1.23-2.77), achievement of blood pressure <140/90 mm Hg (OR: 1.20, 95% CI: 1.03-1.40), LDL recorded (OR: 1.47, 95% CI: 1.05-2.06), and recommendations offered for physical activity (OR: 3.82, 95% CI: 2.23-6.55) or weight management (OR: 1.74, 95% CI: 1.12-2.69). CONCLUSIONS: The GWTG-CAD revascularization hospitals were associated with better performance in some, but not all, measures assessed. Although the difference in conformity between hospital types was modest for performance measures but more variable for quality measures, room for improvement exists in key aspects of care.
No takes yet. Share an insight, caveat, or question.
Thukkani et al. (2014) conducted a cohort in Acute coronary syndromes (n=95,999). Admission to a revascularization-capable hospital vs. Admission to a hospital without revascularization capability was evaluated on Conformity with performance and quality measures. Admission to revascularization-capable hospitals was associated with higher conformity to 8 of 19 care quality measures for ACS patients, including clopidogrel use.
Synapse has enriched 10 related papers. Consider them for comparative context: